Slama, G <br/><br/>
[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study].  [electronic resource] 

 -  Annales d'endocrinologie  Feb 2008 
 - 36-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0003-4266 
<br/><br/><label>Standard No.: </label>10.1016/j.ando.2007.10.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Angiopathies--epidemiology<br/>Diabetic Nephropathies--epidemiology<br/>Follow-Up Studies<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Middle Aged<br/>Myocardial Infarction--epidemiology<br/>Prospective Studies<br/>Rosiglitazone<br/>Thiazolidinediones--therapeutic use<br/>Time Factors